Irbaz B. Riaz

Ethan Cerami, Pavel Trukhanov, Morgan A. Paul et al.

Clinical trials drive improvements in cancer treatments and outcomes. However, most adults with cancer do not participate in trials, and trials often fail to enroll enough patients to answer their scientific questions. Artificial intelligence could accelerate matching of patients to appropriate clinical trials. Here, we describe the development and evaluation of the MatchMiner-AI pipeline for clinical trial searching and ranking. MatchMiner-AI focuses on matching patients to potential trials based on core criteria describing clinical "spaces," or disease contexts, targeted by a trial. It aims to accelerate the human work of identifying potential matches, not to fully automate trial screening. The pipeline includes modules for extraction of key information from a patient's longitudinal electronic health record; rapid ranking of candidate trial-patient matches based on embeddings in vector space; and classification of whether a candidate match represents a reasonable clinical consideration. Code and synthetic data are available at https://huggingface.co/ksg-dfci/MatchMiner-AI . Model weights based on synthetic data are available at https://huggingface.co/ksg-dfci/TrialSpace and https://huggingface.co/ksg-dfci/TrialChecker . A simple cancer clinical trial search engine to demonstrate pipeline components is available at https://huggingface.co/spaces/ksg-dfci/trial_search_alpha .

Niklas Mannhardt, Elizabeth Bondi-Kelly, Barbara Lam et al. · microsoft-research

Large language models (LLMs) have immense potential to make information more accessible, particularly in medicine, where complex medical jargon can hinder patient comprehension of clinical notes. We developed a patient-facing tool using LLMs to make clinical notes more readable by simplifying, extracting information from, and adding context to the notes. We piloted the tool with clinical notes donated by patients with a history of breast cancer and synthetic notes from a clinician. Participants (N=200, healthy, female-identifying patients) were randomly assigned three clinical notes in our tool with varying levels of augmentations and answered quantitative and qualitative questions evaluating their understanding of follow-up actions. Augmentations significantly increased their quantitative understanding scores. In-depth interviews were conducted with participants (N=7, patients with a history of breast cancer), revealing both positive sentiments about the augmentations and concerns about AI. We also performed a qualitative clinician-driven analysis of the model's error modes.

Adarsh Srinivasan, Jacob Dineen, Muhammad Umar Afzal et al.

Large language models in healthcare often miss critical emotional cues, delivering medically sound but emotionally flat advice. This is especially problematic in clinical contexts where patients are distressed and vulnerable, and require empathic communication to support safety, adherence, and trust. We present RECAP (Reflect-Extract-Calibrate-Align-Produce), an inference-time framework that adds structured emotional reasoning without retraining. By decomposing empathy into transparent appraisal-theoretic stages and exposing per-dimension Likert signals, RECAP produces nuanced, auditable responses. Across EmoBench, SECEU, and EQ-Bench, RECAP improves emotional reasoning by 22-28% on 8B models and 10-13% on larger models over zero-shot baselines. Clinician evaluations further confirm superior empathetic communication. RECAP shows that modular, theory-grounded prompting can systematically enhance emotional intelligence in medical AI while preserving the accountability required for deployment.